292.97
price up icon0.10%   0.30
pre-market  Vorhandelsmarkt:  292.97  
loading
Schlusskurs vom Vortag:
$292.67
Offen:
$292.67
24-Stunden-Volumen:
868.15K
Relative Volume:
0.59
Marktkapitalisierung:
$56.78B
Einnahmen:
$310.23B
Nettoeinkommen (Verlust:
$1.69B
KGV:
33.99
EPS:
8.62
Netto-Cashflow:
$3.58B
1W Leistung:
-0.57%
1M Leistung:
-0.23%
6M Leistung:
+18.63%
1J Leistung:
+30.37%
1-Tages-Spanne:
Value
$290.96
$296.49
1-Wochen-Bereich:
Value
$289.47
$298.21
52-Wochen-Spanne:
Value
$218.65
$309.35

Cencora Inc Stock (COR) Company Profile

Name
Firmenname
Cencora Inc
Name
Telefon
610-727-7000
Name
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Name
Mitarbeiter
46,000
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
COR's Discussions on Twitter

Vergleichen Sie COR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Distribution icon
COR
Cencora Inc
292.97 57.11B 310.23B 1.69B 3.58B 8.62
Medical Distribution icon
MCK
Mckesson Corporation
709.47 88.78B 359.05B 3.30B 5.23B 25.83
Medical Distribution icon
CAH
Cardinal Health Inc
157.10 38.43B 222.29B 1.56B 2.44B 6.41
Medical Distribution icon
HSIC
Henry Schein Inc
72.20 8.83B 12.50B 314.00M 421.00M 2.44
Medical Distribution icon
AHG
Akso Health Group Adr
1.99 644.93M 2.22M -5.63M -1.68M -0.24

Cencora Inc Stock (COR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-03 Hochstufung Wells Fargo Equal Weight → Overweight
2024-12-04 Fortgesetzt Mizuho Outperform
2024-09-18 Herabstufung BofA Securities Buy → Neutral
2024-02-26 Eingeleitet Leerink Partners Outperform
2024-01-03 Eingeleitet Barclays Overweight
2023-12-14 Eingeleitet Wells Fargo Equal Weight
2023-03-31 Eingeleitet Citigroup Buy
2023-01-31 Fortgesetzt Evercore ISI Outperform
2022-10-11 Hochstufung BofA Securities Neutral → Buy
2022-08-22 Fortgesetzt Morgan Stanley Equal-Weight
2022-07-11 Herabstufung Evercore ISI Outperform → In-line
2022-06-07 Hochstufung Deutsche Bank Hold → Buy
2022-05-26 Hochstufung Barclays Equal Weight → Overweight
2022-04-12 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-04-01 Fortgesetzt Credit Suisse Outperform
2021-03-12 Fortgesetzt Evercore ISI In-line
2021-02-04 Hochstufung Evercore ISI In-line → Outperform
2021-02-02 Hochstufung Cowen Market Perform → Outperform
2021-01-06 Hochstufung BofA Securities Underperform → Neutral
2021-01-06 Hochstufung Credit Suisse Neutral → Outperform
2020-12-10 Herabstufung Wells Fargo Equal Weight → Underweight
2020-12-03 Eingeleitet Mizuho Neutral
2020-08-06 Hochstufung Raymond James Mkt Perform → Outperform
2020-07-15 Eingeleitet Barclays Underweight
2020-06-15 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-04-23 Fortgesetzt Credit Suisse Outperform
2020-04-16 Herabstufung Raymond James Outperform → Mkt Perform
2020-04-13 Herabstufung Robert W. Baird Outperform → Neutral
2020-04-01 Hochstufung JP Morgan Neutral → Overweight
2020-03-17 Hochstufung Citigroup Neutral → Buy
2020-02-11 Herabstufung BofA/Merrill Buy → Underperform
2020-02-07 Hochstufung Robert W. Baird Neutral → Outperform
2019-09-12 Eingeleitet Deutsche Bank Hold
2019-07-10 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2019-04-11 Eingeleitet Guggenheim Buy
2019-04-10 Herabstufung BofA/Merrill Buy → Underperform
2019-04-10 Herabstufung Evercore ISI Outperform → In-line
2019-02-11 Herabstufung JP Morgan Neutral → Underweight
2019-01-17 Eingeleitet UBS Buy
2018-12-10 Herabstufung Jefferies Buy → Hold
2018-10-26 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2018-09-20 Eingeleitet Berenberg Buy
2018-07-17 Fortgesetzt Stifel Hold
2018-04-09 Eingeleitet MoffettNathanson Buy
2018-03-12 Hochstufung KeyBanc Capital Mkts Sector Weight → Overweight
2018-03-12 Hochstufung Raymond James Mkt Perform → Outperform
2017-09-25 Eingeleitet JP Morgan Neutral
2017-09-22 Eingeleitet William Blair Outperform
Alle ansehen

Cencora Inc Aktie (COR) Neueste Nachrichten

pulisher
02:29 AM

Cencora Inc. Stock Analysis and ForecastFree Investment Case Studies - Autocar Professional

02:29 AM
pulisher
Jul 22, 2025

What analysts say about Cencora Inc. stockUnstoppable profit momentum - Autocar Professional

Jul 22, 2025
pulisher
Jul 20, 2025

Is Cencora Inc. a good long term investmentOutperformance with explosive growth - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Why Cencora Inc. stock is on top investor watchlistsShort Squeeze Radar - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

What drives Cencora Inc. stock priceRecord-breaking gains - Jammu Links News

Jul 18, 2025
pulisher
Jul 17, 2025

Cencora Slumps to 447th in Market Rankings as Trading Volume Drops 40.48 Percent - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Here's Why You Should Add Cencora Stock to Your Portfolio Now - MSN

Jul 17, 2025
pulisher
Jul 16, 2025

Cencora Surges to 261st in Daily Rankings with 3.90 Billion Trading Volume - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora - BioSpace

Jul 16, 2025
pulisher
Jul 15, 2025

Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology Expands Lymphir Distribution With Cencora - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

Citius stock gains on Cencora distribution deal (CTXR:NASDAQ) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 13, 2025

Lobbying Update: $20,000 of CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) lobbying was just disclosed - Quiver Quantitative

Jul 13, 2025
pulisher
Jul 12, 2025

Here's What to Expect From Cencora's Next Earnings Report - MSN

Jul 12, 2025
pulisher
Jul 12, 2025

Cencora, Inc. (COR): If It Was Down, I’d Say “Double Down And Buy,” Says Jim Cramer - Insider Monkey

Jul 12, 2025
pulisher
Jul 11, 2025

Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Jul 11, 2025
pulisher
Jul 10, 2025

Cencora to Announce Q3 2025 Results on August 6 with Live Webcast and Conference Call - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Fund Update: FERGUSON WELLMAN CAPITAL MANAGEMENT, INC added 79,430 shares of CENCORA ($COR) to their portfolio - Quiver Quantitative

Jul 10, 2025
pulisher
Jul 08, 2025

Here's What To Expect From Cencora's Next Earnings Report - Barchart.com

Jul 08, 2025
pulisher
Jul 05, 2025

Cencora Q2 2025 slides: adjusted EPS jumps 16.3%, guidance raised By Investing.com - Investing.com Nigeria

Jul 05, 2025
pulisher
Jul 04, 2025

Cencora Enhances Receivables Purchase Agreement for Liquidity - The Globe and Mail

Jul 04, 2025
pulisher
Jun 30, 2025

Cencora Trading Volume Drops 40.8% to $385 Million Ranking 278th in Market - AInvest

Jun 30, 2025
pulisher
Jun 27, 2025

Mizuho maintains Cencora stock rating on strong Walgreens data - Investing.com

Jun 27, 2025
pulisher
Jun 25, 2025

$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Benzinga

Jun 25, 2025
pulisher
Jun 24, 2025

Cencora's Insider Exodus: Risk or Opportunity? - AInvest

Jun 24, 2025
pulisher
Jun 22, 2025

Cencora Executive VP & Chief Human Resources Officer Silvana Battaglia Sells 27% Of Holding - simplywall.st

Jun 22, 2025
pulisher
Jun 20, 2025

Cencora, Inc.: Insider Selling and Overvaluation—Is This a Red Flag or Opportunity? - AInvest

Jun 20, 2025
pulisher
Jun 20, 2025

Insider Sell: Silvana Battaglia Sells Shares of Cencora Inc (COR) - GuruFocus

Jun 20, 2025
pulisher
Jun 18, 2025

Three fund managers share picks for tariff-resistant U.S. stocks - The Globe and Mail

Jun 18, 2025
pulisher
Jun 17, 2025

$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today - Benzinga

Jun 17, 2025
pulisher
Jun 15, 2025

Cencora Welcomes Lori J. Ryerkerk to Board of Directors - MSN

Jun 15, 2025
pulisher
Jun 12, 2025

Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 12, 2025
pulisher
Jun 12, 2025

Cardinal Health boosts profit view banking on specialty drugs unit growth - Reuters

Jun 12, 2025
pulisher
Jun 10, 2025

Is Cencora Stock Outperforming The Dow? - Barchart.com

Jun 10, 2025
pulisher
Jun 10, 2025

Is Cencora Stock Outperforming the Dow? - The Globe and Mail

Jun 10, 2025
pulisher
Jun 09, 2025

Cencora, Inc. (COR) Enhances Financial Flexibility with Amended Credit Agreements - GuruFocus

Jun 09, 2025
pulisher
Jun 06, 2025

Cencora Enhances Financial Flexibility with Credit Amendments - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Cencora IncIncreases Revolving Credit Facility To $4.5 Billion - MarketScreener

Jun 06, 2025
pulisher
Jun 06, 2025

Cardinal Health, Cencora upgraded at Wells Fargo on industry outlook - MSN

Jun 06, 2025

Finanzdaten der Cencora Inc-Aktie (COR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_distribution CAH
$157.10
price down icon 0.93%
medical_distribution MCK
$709.47
price down icon 0.24%
$72.20
price up icon 4.53%
medical_distribution AHG
$1.99
price down icon 1.73%
medical_distribution OMI
$8.10
price up icon 4.65%
Kapitalisierung:     |  Volumen (24h):